Grapefruit, Pomegranate and Starfruit: — Why They're Banned on Many Cancer Drugs

The effect on CYP3A4 enzymes can last 24 hours or more after eating grapefruit or drinking its juice. This is why spacing it away from your dose does not make it safe — a glass of grapefruit juice in the morning can still affect drug levels from an evening dose. For simplicity and safety, most oncology teams advise cutting it out entirely for the duration of treatment rather than trying to time it.

Juice is often considered a higher risk because it is easy to consume in larger quantities, but both the whole fruit and the juice contain the furanocoumarin compounds that block CYP3A4. The interaction is not about the sugar or the fibre. Both should be avoided. If you have consumed either form and are unsure of the timing relative to your medication, tell your oncology team before your next dose.

Pomegranate can inhibit CYP3A4 and is flagged alongside grapefruit in oncology guidance for several oral cancer medicines. The research base for pomegranate is smaller than for grapefruit, but that does not mean the risk is smaller — it means there is less certainty. In a situation involving cancer treatment, less certainty is not a reason to proceed. Avoid it unless your oncologist or pharmacist has specifically told you it is safe with your drug.

Starfruit's interaction with drug metabolism involves CYP3A4 and other absorption pathways, but the practical advice is the same: avoid it during treatment. Starfruit also contains compounds that can affect the kidneys, which makes it separately risky for patients whose treatment already places a load on kidney function. It is sometimes overlooked in conversations because it is less commonly eaten — ask your team specifically if they have not mentioned it.

Tell your oncology team before your next dose. Do not skip your medication without speaking to them, but do not take it either before they know what happened. They will need to know roughly how much you ate and how long ago. Depending on your drug and the timing, they may adjust your dose, delay the next one, or ask you to come in for monitoring. This is a clinical decision your team needs to make — it cannot be safely managed at home.

Yes. Not all cancer medicines are metabolised through CYP3A4, so grapefruit does not affect all of them. Many intravenous chemotherapy medicines given as infusions are unaffected. Your pharmacist is the best person to check for your specific drug — they can look at how your medicine is processed and give you a clear answer. Do not assume that because a drug is a tablet it is automatically affected, or that because it is an infusion it is automatically safe.

Seville oranges — the bitter variety used in traditional marmalade — contain the same furanocoumarin compounds as grapefruit and carry the same CYP3A4 warning. Pomelo also shares genetic overlap with grapefruit and has been flagged in similar interactions. Standard sweet oranges, lemons, and limes are not thought to carry this risk. If you are unsure what variety of orange was used in a product, avoid it and choose something else — it is not worth the uncertainty.

Several supplements also affect CYP3A4 — in some cases making it work faster rather than blocking it. St John's Wort is the most significant example and can cause cancer drugs to be cleared from the body too quickly, reducing their effect. NCCN and ESMO guidance consistently advises telling your oncology team about everything you are taking, including herbal supplements, vitamins, ayurvedic preparations, and traditional medicines. A complete list is more useful to your team than a partial one. When in doubt, bring the bottle to your appointment.